Molecular Modeling of Brassicaceae Derivatives for Inhibiting Lipoxygenases: A Promising Therapeutic Strategy

Q3 Pharmacology, Toxicology and Pharmaceutics Current drug discovery technologies Pub Date : 2023-12-14 DOI:10.2174/0115701638269042231122064738
W. Soufi, H. Allali, F. B. Hacene, S. Ghalem
{"title":"Molecular Modeling of Brassicaceae Derivatives for Inhibiting\nLipoxygenases: A Promising Therapeutic Strategy","authors":"W. Soufi, H. Allali, F. B. Hacene, S. Ghalem","doi":"10.2174/0115701638269042231122064738","DOIUrl":null,"url":null,"abstract":"\n\nInflammation plays a crucial role in the body's defense mechanisms, but\nuncontrolled inflammation can lead to chronic and pathological conditions. This study aimed to\nidentify natural compounds as potential replacements for the synthetic drug Zileuton, known for its\nside effects.\n\n\n\nUtilizing the MOE and Molegro modeling methods, several molecules were evaluated, and\nthree compounds, namely 1-Isothiocyanatopent-4-en-2-ol, 7-Isothiocyanatohept-1-ene, and 5-\n(Isothiocyanatomethyl)-1,2,3-trimethoxybenzene, exhibited superior inhibitory properties. These\ncompounds consistently demonstrated low energy values, indicating high inhibition potency. Notably, 5-(Isothiocyanatomethyl)-1,2,3-trimethoxybenzene emerged as the most promising candidate\namong all tested compounds.\n\n\n\nThese findings provide valuable insights for the development of alternative anti-inflammatory agents. Further research is required to assess the efficacy and safety profiles of these compounds\nin clinical settings.\n\n\n\nThis study represents a significant advancement in the search for innovative therapeutic strategies to manage inflammation-related disorders.\n","PeriodicalId":10858,"journal":{"name":"Current drug discovery technologies","volume":"50 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug discovery technologies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115701638269042231122064738","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0

Abstract

Inflammation plays a crucial role in the body's defense mechanisms, but uncontrolled inflammation can lead to chronic and pathological conditions. This study aimed to identify natural compounds as potential replacements for the synthetic drug Zileuton, known for its side effects. Utilizing the MOE and Molegro modeling methods, several molecules were evaluated, and three compounds, namely 1-Isothiocyanatopent-4-en-2-ol, 7-Isothiocyanatohept-1-ene, and 5- (Isothiocyanatomethyl)-1,2,3-trimethoxybenzene, exhibited superior inhibitory properties. These compounds consistently demonstrated low energy values, indicating high inhibition potency. Notably, 5-(Isothiocyanatomethyl)-1,2,3-trimethoxybenzene emerged as the most promising candidate among all tested compounds. These findings provide valuable insights for the development of alternative anti-inflammatory agents. Further research is required to assess the efficacy and safety profiles of these compounds in clinical settings. This study represents a significant advancement in the search for innovative therapeutic strategies to manage inflammation-related disorders.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
用于抑制脂氧合酶的十字花科衍生物的分子模型:一种前景广阔的治疗策略
炎症在人体的防御机制中起着至关重要的作用,但不加控制的炎症会导致慢性病症。利用 MOE 和 Molegro 建模方法,对几种分子进行了评估,结果表明 1-异硫氰基-4-烯-2-醇、7-异硫氰基-1-庚烯和 5-(异硫氰基甲基)-1,2,3-三甲氧基苯这三种化合物具有优异的抑制特性。这些化合物的能量值一直很低,表明它们具有很高的抑制效力。值得注意的是,在所有测试化合物中,5-(异硫氰基甲基)-1,2,3-三甲氧基苯成为最有希望的候选化合物。这项研究标志着在寻找创新治疗策略以控制炎症相关疾病方面取得了重大进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current drug discovery technologies
Current drug discovery technologies Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
CiteScore
3.70
自引率
0.00%
发文量
48
期刊介绍: Due to the plethora of new approaches being used in modern drug discovery by the pharmaceutical industry, Current Drug Discovery Technologies has been established to provide comprehensive overviews of all the major modern techniques and technologies used in drug design and discovery. The journal is the forum for publishing both original research papers and reviews describing novel approaches and cutting edge technologies used in all stages of drug discovery. The journal addresses the multidimensional challenges of drug discovery science including integration issues of the drug discovery process.
期刊最新文献
Harnessing the Therapeutic Potential of Dillenia indica: An Overview of Recent Dosage Form Developments. New 1,3,4‒oxadiazole Quinazolines as Potential Anticancer Agents: Design, Synthesis, Biological Evaluation, and In silico Studies. Nanoencapsulation of Ruthenium Complex Ru(ThySMet): A Strategy to Improve Selective Cytotoxicity against Breast Tumor Cells in 2D and 3D Culture Models. CBD: A Potential Lead against Hair Loss, Alopecia, and its Potential Mechanisms. The Nanotech Potential of Curcumin in Pharmaceuticals: An Overview.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1